Loading Programs

Available Programs

Programs Search and Views Navigation

December 2020

  • ONLINE ON-DEMAND

Changing Course: Reversing Direct Oral Anticoagulants in the Emergency Department

December 1, 2020 - December 1, 2021

The development of direct oral anticoagulants (DOACs) has advanced the therapeutic landscape for the management of thromboembolic events. Specific agents that rapidly reverse the effects of DOACs are now available and offer safe and effective options for patients who experience an emergency DOAC-associated bleeding event. This interactive activity will offer clinical pearls for the assessment of bleeding severity in patients receiving DOACs; expert-guided insights to rapid reversal of urgent DOAC-associated bleeding; and clinical decision support tools to optimize outcomes in…

Find out more »
  • ONLINE ON-DEMAND

Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease

December 2, 2020 - December 2, 2021

Acute graft-versus-host disease (aGVHD) is a common complication of allogeneic hematopoietic stem cell transplantation and is a major cause of morbidity and mortality. While systemic corticosteroids are traditional first-line treatment for aGVHD, about half of patients are refractory to therapy. So what options are available for the treatment of steroid-refractory aGVHD? Join Doris Ponce, MD, and Corey Cutler, MD, MPH, for this podcast as they discuss different novel therapeutic options for managing aGVHD refractory to steroids. This activity is jointly…

Find out more »
  • ONLINE ON-DEMAND

Following the Trail of Evidence to Individualize and Optimize Multiple Sclerosis Care: Clinical Insights on When and How to Switch DMT in Patients with a Suboptimal Treatment Response

December 21, 2020 - December 21, 2021

Multiple sclerosis (MS) is a progressive disease that causes irreversible damage to the central nervous system (CNS). This disabling neurologic disease is one of the most common causes of disability in individuals between the ages of 10 and 65 years old. It presents with a wide range of symptoms and therefore has a variable impact on motor and cognitive function, activities of daily living, and patient quality of life. Three-fourths of MS patients eventually become significantly disabled by this condition.…

Find out more »
  • ONLINE ON-DEMAND

Following the Trail of Evidence to Individualize and Optimize Multiple Sclerosis Care: Examining the Evidence for Early Initiation of Disease-Modifying Therapy

December 21, 2020 - December 21, 2021

Multiple sclerosis (MS) is a progressive disease that causes irreversible damage to the central nervous system (CNS). This disabling neurologic disease is one of the most common causes of disability in individuals between the ages of 10 and 65 years old. It presents with a wide range of symptoms and therefore has a variable impact on motor and cognitive function, activities of daily living, and patient quality of life. Three-fourths of MS patients eventually become significantly disabled by this condition.…

Find out more »
  • ONLINE ON-DEMAND

Following the Trail of Evidence to Individualize and Optimize Multiple Sclerosis Care: Exploring the Use of Diagnostic Tools to Improve Early Detection of MS

December 21, 2020 - December 21, 2021

Multiple sclerosis (MS) is a progressive disease that causes irreversible damage to the central nervous system (CNS). This disabling neurologic disease is one of the most common causes of disability in individuals between the ages of 10 and 65 years old. It presents with a wide range of symptoms and therefore has a variable impact on motor and cognitive function, activities of daily living, and patient quality of life. Three-fourths of MS patients eventually become significantly disabled by this condition.…

Find out more »
  • ONLINE ON-DEMAND

Moving the Needle: Collaborative Strategies to Overcome Barriers to Insulin Initiation and Adherence – Patient and Provider Barriers to Insulin Uptake and Adherence

December 22, 2020 - December 22, 2021

Diabetes represents a significant national and global health concern, affecting nearly 11% of the population in the United States. Despite established benefits of insulin, it continues to be underused and many patients fail to achieve glycemic goals. Three 15-minute CME modules will review patient and clinician barriers that delay insulin initiation, communication strategies to address barriers to insulin therapy, and how to develop patient-specific plans for insulin therapy according to clinical and safety data. These educational activities will prepare clinicians…

Find out more »
  • ONLINE ON-DEMAND

Moving the Needle: Collaborative Strategies to Overcome Barriers to Insulin Initiation and Adherence – Recommendations for the Role and Use of Insulin

December 22, 2020 - December 22, 2021

Diabetes represents a significant national and global health concern, affecting nearly 11% of the population in the United States. Despite established benefits of insulin, it continues to be underused and many patients fail to achieve glycemic goals. Three 15-minute CME modules will review patient and clinician barriers that delay insulin initiation, communication strategies to address barriers to insulin therapy, and how to develop patient-specific plans for insulin therapy according to clinical and safety data. These educational activities will prepare clinicians…

Find out more »
  • ONLINE ON-DEMAND

Moving the Needle: Collaborative Strategies to Overcome Barriers to Insulin Initiation and Adherence – Strategies to Improve Uptake and Adherence to Insulin

December 22, 2020 - December 22, 2021

Diabete-s represents a significant national and global health concern, affecting nearly 11% of the population in the United States. Despite established benefits of insulin, it continues to be underused and many patients fail to achieve glycemic goals. Three 15-minute CME modules will review patient and clinician barriers that delay insulin initiation, communication strategies to address barriers to insulin therapy, and how to develop patient-specific plans for insulin therapy according to clinical and safety data. These educational activities will prepare clinicians…

Find out more »
  • ONLINE ON-DEMAND

The Time Is Now: Advancing the Care of Adolescent and Adult Patients With Sickle Cell Disease

December 31, 2020 - December 31, 2021

Did you know the average life span of Americans with sickle cell disease is 20 to 30 years less than those without sickle cell disease? New clinical approaches and treatments can lead to increased survival. In this 30-minute CME activity, Dr Biree Andemariam and Dr Laura De Castro explore current evidence-based approaches, review available agents, and discuss strategies to encourage clinical trial participation among patients. Join us to learn the latest information on this challenging disease. https://www.mycme.com/courses/the-time-is-now-advancing-the-care-of-adolescent-and-adult-patients-with-sickle-cell-disease-7500    

Find out more »

February 2021

  • ONLINE ON-DEMAND

Team Up Against MS: The Multidisciplinary Patient-Centered Team Approach to Multiple Sclerosis – Podcast

February 8, 2021 - February 8, 2022

Patients with multiple sclerosis (MS) often need the intervention of multiple specialists, resulting in a complex organization of care. Listen in to this team of healthcare professionals from the MS Comprehensive Care Center at Holy Name Medical Center, who share their insights on best practices for patient-centered care of people with MS. The MS Care Team share key aspects of their evolution as a team using two cases of patients with MS. This discussion highlights how they 1) evaluate existing…

Find out more »
  • ONLINE ON-DEMAND

New Therapeutic Options in AML: An Update for Community Clinicians – Podcast

February 11, 2021 - February 11, 2022

Have you heard about the latest clinical advances in AML therapy? Recent approvals and emerging therapies, such as epigenetic agents and newer cytotoxics, has transformed the care of patients with newly diagnosed and relapsed/refractory AML. Join Dr Stephen A. Strickland and Dr Eunice S. Wang as they discuss recent science that provides guidance for the care team on the use of newly approved and novel strategies for AML management. Click here to listen to this 45-minute CME podcast: https://www.mycme.com/courses/new-therapeutic-options-in-aml-an-update-for-community-clinicians-7573

Find out more »
  • ONLINE ON-DEMAND

Clinical Pearls for Advanced Practice Providers: Reversing Direct Oral Anticoagulants in the Emergency Department – ACEP Frontline Podcast

February 15, 2021 - February 15, 2022

This online educational podcast offers clinical pearls for the assessment of bleeding severity in patients receiving DOACs; expert-guided insights to rapid reversal of urgent DOAC-associated bleeding; and practical strategies for aligning clinical practice with local hospital bleeding management protocols. Join Dr Colin Kaide and Eric Cucchi as they examine the latest recommendations for the management of life-threatening DOAC-associated bleeding. Click here to enroll and listen to this 37-minute ACEP Frontline Podcast: https://www.acep.org/education/podcasts-and-apps/  

Find out more »
  • ONLINE ON-DEMAND

HER-Directed Therapies in Metastatic Breast Cancer: Safety and Efficacy Considerations

February 22, 2021 - February 22, 2022

Despite advances in HER targeting, HER2-positive metastatic breast cancer typically progresses. Research has established that the HER2-HER3 complex is the true driver of HER2-amplified cancer and the effective inactivation of this complex is the new bar for novel therapies. In this interactive educational activity, Dr Hurvitz and Dr Tolaney share key data and expert perspectives on recently approved and emerging HER-targeted therapies for metastatic breast cancer. Sara A. Hurvitz, MD, FACP, Professor of Medicine, Director, Breast Oncology Program, Division of…

Find out more »
  • ONLINE ON-DEMAND

Getting Ahead of Migraine: Best Practices for Migraine Prevention – Targeting CGRP for Migraine Prevention

February 26, 2021 - February 26, 2022

Four anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies are approved for migraine prevention. To ensure clinicians are prepared to consider these agents when clinically indicated, this educational activity will compare the efficacy and safety of these therapies for migraine prevention and discuss strategies for shared decision-making. Cynthia E. Armand, MD, Assistant Professor of Neurology Albert Einstein College of Medicine, Fellowship Director Montefiore Headache Center, Bronx, NY Carrie Dougherty, MD, FAHS, Associate Professor of Neurology Program Director, Headache Medicine Fellowship, Assistant Program Director, Neurology…

Find out more »
  • ONLINE ON-DEMAND

Getting Ahead of Migraine: Best Practices for Migraine Prevention – Migraine Diagnosis and Burden of Disease

February 26, 2021 - February 26, 2022

My migraines made me feel like I was a part-time parent. They were so bad that my husband and I came to the difficult decision that we could not have more kids because I could not function as a parent ‒ I could barely function as an adult.” Do you know how migraine affects the daily lives of your patients? Join Dr Cynthia Armand and Dr Carrie Dougherty to learn more about caring for patients with this debilitating disease. Cynthia…

Find out more »

March 2021

  • ONLINE ON-DEMAND

Tackling Challenging MS Case Scenarios: Evaluating Missed Opportunities to Improve Care

March 15, 2021 - March 15, 2022

Multiple sclerosis (MS) is a chronic neurodegenerative disease with a complex clinical course, and many health care professionals may miss opportunities to deliver evidence-based care. Join our expert faculty as they discuss patient scenarios to highlight methods to avoid missed opportunities to provide optimal care for patients with MS. Patient scenario one:  A Latina Woman With Relapsing-Remitting MS Planning to Have a Child Click here to view this 15-minute activity: https://realcme.realcme.com/learner/course/2798 Patient scenario two: An African American Male With Vision…

Find out more »
  • ONLINE ON-DEMAND

Psoriatic Arthritis: Therapeutic Advances and Expert Perspectives on Managing Psoriatic Arthritis

March 22, 2021 - March 22, 2022

Are you confident tailoring therapies for patients with psoriatic arthritis? In this 60-minute panel discussion, four faculty experts will discuss evaluating patients for potential signs and symptoms to ensure timely and accurate diagnosis, review mechanisms and clinical data for new and emerging agents, and determine patient- and disease-specific therapeutic approaches for psoriatic arthritis. Join Drs. Menter, Mease, Merola, and Craig to learn about the latest in psoriatic arthritis management.   Click on any of these links to register and start…

Find out more »

April 2021

  • ONLINE ON-DEMAND

Precision Medicine in Non-Small Cell Lung Carcinoma: New Paradigms and Best Practices in Targeted Therapy

April 14, 2021 - April 14, 2022

Join Dr Ross Camidge and Dr Mark Socinski as they share insights into the selection of precision therapy for NSCLC based on tumor biomarkers and driver mutations, and strategies to proactively address treatment-related adverse events. Click here to access this 30-minute activity worth 0.50 / AMA PRA Category 1 Credit(s)TM https://www.mycme.com/courses/precision-medicine-in-non-small-cell-lung-carcinoma-new-paradigms-and-best-practices-in-targeted-therapy-7664

Find out more »

May 2021

  • ONLINE ON-DEMAND

Best Practices for Disease Detection, Risk Stratification, and Treatment Selection in Osteoporosis

May 6, 2021 - May 6, 2022

Are you confident implementing recent osteoporosis recommendations in your clinical practice? Despite clear guidance, screening rates remain suboptimal and many clinicians are hesitant to implement pharmacologic therapy. This 15-minute case-based CME activity, developed by osteoporosis experts Dr Rachel Pessah-Pollack and Dr Steven Petak, addresses screening, diagnosis, treatment strategies, and patient-specific treatment considerations for osteoporosis. https://realcme.com/learner/course/2812

Find out more »
  • ONLINE ON-DEMAND

Current Concepts in Diagnosing and Treating Alzheimer’s Disease

May 10, 2021 - May 10, 2022

Are you confident diagnosing and treating patients with Alzheimer’s disease? This 30-minute video activity offers pearls to optimize care for patients with this challenging neurological disease. Join Dr Zoe Arvanitakis and Dr Marwan Sabbagh as these experts discuss the importance of an early and accurate diagnosis, review current agents and treatment strategies, and highlight emerging disease-modifying agents that could change the way Alzheimer’s disease is approached in the future. Expert insights from the 2021 AD/PD Conference are also addressed in…

Find out more »
  • ONLINE ON-DEMAND

Making a Difference in Patients with Spinal Muscular Atrophy: Improving Diagnosis and Treatment

May 11, 2021 - May 11, 2022

Spinal muscular atrophy (SMA) is an inherited condition that places a tremendous burden on patients, families, caregivers, and healthcare providers, with patients experiencing a wide range of complications and symptoms that are detrimental to day-to-day life. Although SMA management has historically consisted of supportive care, the therapeutic landscape has changed dramatically following the recent approval of transformative medications, particularly disease-modifying therapies (DMTs) that improve motor function and survival. In this educational activity, experts Dr Basil Darras and Dr Julie Parsons,…

Find out more »

June 2021

  • ONLINE ON-DEMAND

The Role of Telehealth in Pediatric and Adult Infections: Best Practices and Care Considerations for Influenza

June 18, 2021 - June 18, 2022

Are you prepared to manage influenza in the era of COVID-19? Listen to Dr Paul G. Auwaerter’s and Dr Javeed Siddiqui’s discussion on the challenges of influenza management in the midst of the COVID-19 pandemic. Explore solutions to your questions about best practices to assess influenza via telehealth, strategies for influenza prophylaxis, and selecting antivirals for children, adolescents, and adults, including patients at high risk of influenza complications. Click here to enter this activity: https://learning.freecme.com/a/37397P2C6ABt

Find out more »
  • ONLINE ON-DEMAND

A Multidisciplinary Team Approach to Patient-Centric Management of Fabry Disease – Gather-ed

June 28, 2021 - June 28, 2022

Patients with Fabry disease have a significantly shorter life expectancy compared to the general population, often due to cardiac or renal complications of this rare disease. There are only 2 approved therapies for Fabry disease—enzyme replacement therapy and chaperone therapy. Management of Fabry disease and its complications is a rapidly evolving field with ongoing developments, from recent guideline recommendations to new data on approved therapies to promising clinical trials on investigational therapies. Timely and proper management is essential to slow…

Find out more »
+ Export Events